Forbes January 10, 2023
Two prestigious research institutes, Baylor Scott and White Health and the Translational Genomics Research Institute (TGen), announced today a new research study aimed at analyzing cancer resistance mechanisms using several multiomics technologies, in collaboration with Israeli startup OncoHost.
Baylor Scott and White Health is the largest not-for-profit health system in the state of Texas, with 51 hospitals and more than 1,100 access points serving more than three million Texans. The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases.
OncoHost has developed a precision oncology platform, a plasma-based, proprietary...
Today's Sponsors
Today's Sponsor